EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID ‐19 patients with type 2 diabetes: A target trial emulation study

Eric Y F Wan iD, Zoey C T Wong, Vincent K C Yan, Celine S L Chui, Francisco T T Lai, Xue Li, Ian C K Wong, Esther W Y Chan

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15830 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Eric Y F Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Ko…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Ritonavir, COVID-19 Drug Treatment, Hospitalization. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health and Medical Research Fund, Food and Health Bureau, University Grants Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims To compare the effectiveness of molnupiravir and nirmatrelvir‐ritonavir for non‐hospitalized and hospitalized COVID‐19 patients with type 2 diabetes (T2DM). Materials and Methods Territory‐wide electronic health records in Hong Kong were used to perform target trial emulation using a sequential trial approach. Patients (1) aged ≥18 years, (2) with T2DM, (3) with COVID‐19 infection, and (4) who received molnupiravir or nirmatrelvir‐ritonavir within 5 days of infection between 16 March 2022 and 31 December 2022 in non‐hospital and hospital settings were included. Molnupiravir and nirmatrelvir‐ritonavir initiators were matched using one‐to‐one propensity‐score matching and followed for 28 days. Risk of outcomes was compared between groups by Cox regression adjusted for baseline characteristics. Subgroup analyses were performed on age (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2RitonavirCOVID-19 Drug TreatmentHospitalizationCytidineAntiviral AgentsHumansMaleFemaleMiddle AgedAgedSARS-CoV-2Hong KongLeucineHydroxylaminesTreatment OutcomeCOVID-19Drug Therapy, CombinationIndolesAdultLactamsNitrilesProline

Stichwörter der Autor:innen

effectivenesspharmacoepidemiologyreal‐world evidencetype 2 diabetes

Substanzen

RitonavirCytidinemolnupiravirAntiviral AgentsnirmatrelvirLeucineHydroxylaminesIndolesLactamsNitriles

Autor:innen und Institutionen

  • Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China.
  • Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.

ORCID-Profile: Eric Y F Wan

Förderung

  • Health and Medical Research Fund
  • Food and Health Bureau
  • University Grants Committee

Zitieren

APA

Wan, E. Y. F., Wong, Z. C. T., Yan, V. K. C., Chui, C. S. L., Lai, F. T. T., Li, X., Wong, I. C. K., & Chan, E. W. Y. (2024). Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID ‐19 patients with type 2 diabetes: A target trial emulation study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15830

Vancouver

Wan EYF, Wong ZCT, Yan VKC, Chui CSL, Lai FTT, Li X, et al. Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID ‐19 patients with type 2 diabetes: A target trial emulation study. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15830

BibTeX
@article{Wan2024,
  author = {Wan, Eric Y F and Wong, Zoey C T and Yan, Vincent K C and Chui, Celine S L and Lai, Francisco T T and Li, Xue and Wong, Ian C K and Chan, Esther W Y},
  title = {Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID ‐19 patients with type 2 diabetes: A target trial emulation study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15830}
}
Kostenlos starten →